Table 2.
Model System | BPs Exposure System/ | Main Outcomes | Reference |
---|---|---|---|
Dose/Period | |||
Male rats | Oral administration by gavage BPS (30, 60, and 120 mg·kg−1 BW)/daily for 30 days |
↑ Serum glucose ↑ Total cholesterol, triglyceride, glycerol-free triglyceride, and LDL ↓ HDL |
[38] |
Male rats | Administered with drinking water BPA or BPS (0.05 mg·kg−1 BW)/38 weeks |
↑ BW by 14% after 32 weeks ↑ Triglycerides ↑ Blood glucose No effects with BPA |
[39] |
Female mice | Oral administration by gavage BPS (0.5, 5, and 50 mg·kg−1 BW)/daily for 2 weeks |
BPS at 5 mg·kg−1 BW dose: ↑ BW by 31% ± 4% ↑ Visceral fat formation (emerged more with BPS exposure but not with BPA) BPS at 50 mg·kg−1 BW dose: ↑ ALT and AST |
[40] |
Zebrafish | Diluted in water (refreshed daily) BPS (1, 10, and 100 µg·L−1)/15 days |
↑ Visceral fat accumulation ↑ Triacylglycerol |
[41] |
Zebrafish | Diluted in water (refreshed daily) BPS (1, 10, 100, and 1000 µg·L−1)/120 days |
In males: ↑ FFA, triacylglycerol, total cholesterol, and LDL ↑ Fat accumulation in the liver In females: ↑ FFA emerged with (1000 µg·L−1) |
[42] |
Adipose hASCs | BPs solution added to media BPS or BPF (0.01, 0.1, 1, 10, and 25 μM)/14 days |
↑ Lipid accumulation ↑ Adipogenesis |
[43] |
Murine 3T3-L1 preadipocytes | BPs solution added to media (replaced and refreshed every 2 days) BPA or BPS (0.01–50 μM)/6 days |
↑ Lipid accumulation ↑ Upregulation of adipogenic genes expression (emerged more in BPS than BPA) |
[44] |
Murine 3T3-L1 preadipocytes | BPs solution added to media (replaced and refreshed every other day) BPA, BPS, or BPF (10 nM)/12 days |
↑ Lipid accumulation with BPS, followed by BPA BPF had the least impact |
[45] |
Male mice | Administered with chow BPF (0, 0.5, 5, and 50 mg·kg−1 chow ≈ 0.044, 0.44, and 4.4 mg·kg−1 BW)/daily for 12 weeks |
Mice gained less weight than controls No effects on glucose levels or glucose tolerance |
[45] |
Male rats | Oral administration by gavage BPS (0.05, 0.5, and 5 mg·kg−1 BW)/daily for 90 days |
With median and high doses: ↑ Blood glucose ↓ Insulin response ↑ Disturbances in glycolysis and gluconeogenesis |
[29] |
Male zebrafish | Diluted in water (refreshed daily) BPS (1 and 10 μg·L−1)/28 days |
↑ FBG ↓ Insulin levels |
[46] |
HFD-induced male mice | Oral administration by gavage to dams BPS (0.1 mg·kg−1 BW)/daily from gestational day 7 to postnatal day 21 |
Compared to HFD-induced offspring of dams not exposed to BPS: ↑ BW ↑ Triglycerides and total cholesterol ↑ Lipid accumulation in liver tissues and epididymal white adipose tissues |
[47] |
HFD-induced male mice | Administered with drinking water of dams BPS (0.05, 0.5, 5, and 50 mg·kg−1 BW)/daily from gestation day 9 until delivery |
↑ Adipocytes size in gonadal white adipose tissue of offspring (gonadal adipocyte hypertrophy) | [48] |
Abbreviations: BPs: bisphenols; BPA: bisphenol A; BPS; bisphenol S; BPF: bisphenol F; BW: body weight; LDL: low-density lipoprotein; HDL: high-density lipoprotein; FFA: free fatty acids; HFD: high-fat diet; hASCs, human adipose-derived stem cells; ALT: alanine aminotransferase; AST: aspartate aminotransferase; FBG: fasting blood glucose; (↑): increase; (↓): decrease.